HOW CAN WE ENSURE EQUITABLE ACCESS TO THE COVID-19 VACCINE?
Building Racial Equity into the Drug Development System
Measuring the Impact of Medicines Patent Pool Licenses: A Civil Society Assessment
Why UNITAID Matters for People Living with HIV/AIDS, TB and Malaria – Market Impact Report by the Civil Society Delegations Civil Society Assessment Presentation